{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T04:28:20Z","timestamp":1780547300799,"version":"3.54.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T00:00:00Z","timestamp":1704931200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010665","name":"H2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["955756"],"award-info":[{"award-number":["955756"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.xphs.2024.01.001","type":"journal-article","created":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T12:06:37Z","timestamp":1704974797000},"page":"1546-1554","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Understanding the Conditions Under Which Drugs are Transferred from the Stomach Through the Upper Small Intestine After a High-Calorie, High-Fat Meal"],"prefix":"10.1016","volume":"113","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-4880-509X","authenticated-orcid":false,"given":"Shirin","family":"Dietrich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3878-8206","authenticated-orcid":false,"given":"Jens","family":"Ceulemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4725-3107","authenticated-orcid":false,"given":"Eline","family":"Hermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodoros","family":"Argyropoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Goumas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4463-2459","authenticated-orcid":false,"given":"Maria","family":"Vertzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6958-2147","authenticated-orcid":false,"given":"Christos","family":"Reppas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.xphs.2024.01.001_bib0001","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.1021\/acs.molpharmaceut.7b00396","article-title":"In silico modeling approach for the evaluation of gastrointestinal dissolution, supersaturation, and precipitation of posaconazole","volume":"14","author":"Hens","year":"2017","journal-title":"Mol Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2024.01.001_bib0002","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.xphs.2018.10.051","article-title":"Integration of precipitation kinetics from an in vitro, multicompartment transfer system and mechanistic oral absorption modeling for pharmacokinetic prediction of weakly basic drugs","volume":"108","author":"Patel","year":"2019","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2024.01.001_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.122670","article-title":"Usefulness of the BioGIT system in screening for differences in early exposure in the fasted state on an a priori basis","volume":"634","author":"Kostantini","year":"2023","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2024.01.001_bib0004","unstructured":"FDA. 2022. Assessing the effects of food on drugs in INDs and NDAs \u2014 clinical pharmacology considerations guidance for industry. ed."},{"key":"10.1016\/j.xphs.2024.01.001_bib0005","unstructured":"EMA. 2012. EMA. European Medicines Agency updates guideline on drug interactions. ed."},{"issue":"7","key":"10.1016\/j.xphs.2024.01.001_bib0006","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1023\/A:1015827908309","article-title":"Upper gastrointestinal (GI) pH in young, healthy men and women","volume":"7","author":"Dressman","year":"1990","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2024.01.001_bib0007","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jconrel.2015.10.022","article-title":"Intragastric pH and pressure profiles after intake of the high-caloric, high-fat meal as used for food effect studies","volume":"220","author":"Koziolek","year":"2015","journal-title":"J Control Release"},{"issue":"5","key":"10.1016\/j.xphs.2024.01.001_bib0008","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1021\/mp500022u","article-title":"Intragastric volume changes after intake of a high-caloric, high-fat standard breakfast in healthy human subjects investigated by MRI","volume":"11","author":"Koziolek","year":"2014","journal-title":"Mol Pharm"},{"key":"10.1016\/j.xphs.2024.01.001_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105535","article-title":"Characteristics of contents in the upper gastrointestinal lumen after a standard high-calorie high-fat meal and implications for the in vitro drug product performance testing conditions","volume":"155","author":"Pentafragka","year":"2020","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.xphs.2024.01.001_bib0010","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0378-5173(87)90137-2","article-title":"Gastrointestinal transit of a controlled release pellet formulation of tiaprofenic acid and the effect of food","volume":"35","author":"Davis","year":"1987","journal-title":"Int J Pharmaceut"},{"issue":"2","key":"10.1016\/j.xphs.2024.01.001_bib0011","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.ejpb.2008.05.011","article-title":"Bioavailability of amoxicillin and clavulanic acid from extended release tablets depends on intragastric tablet deposition and gastric emptying","volume":"70","author":"Weitschies","year":"2008","journal-title":"Eur J Pharm Biopharm"},{"issue":"3","key":"10.1016\/j.xphs.2024.01.001_bib0012","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0378-5173(87)90182-7","article-title":"The influence of food on the gastric emptying of multiparticulate dosage forms","volume":"34","author":"O'Reilly","year":"1987","journal-title":"Int J Pharm"},{"issue":"5","key":"10.1016\/j.xphs.2024.01.001_bib0013","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1023\/A:1007568900147","article-title":"Bioequivalence study of stressed and nonstressed hard gelatin capsules using amoxicillin as a drug marker and gamma scintigraphy to confirm time and GI location of in vivo capsule rupture","volume":"17","author":"Digenis","year":"2000","journal-title":"Pharm Res"},{"issue":"10","key":"10.1016\/j.xphs.2024.01.001_bib0014","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1023\/A:1026155822121","article-title":"Comparison of the rates of disintegration, gastric emptying, and drug absorption following administration of a new and a conventional paracetamol formulation, using gamma scintigraphy","volume":"20","author":"Kelly","year":"2003","journal-title":"Pharm Res"},{"issue":"5","key":"10.1016\/j.xphs.2024.01.001_bib0015","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1023\/B:PHAM.0000026430.73789.e6","article-title":"Wilding IR. In vitro and in vivo pharmacoscintigraphic evaluation of ibuprofen hypromellose and gelatin capsules","volume":"21","author":"Cole","year":"2004","journal-title":"Pharm Res"},{"issue":"1-2","key":"10.1016\/j.xphs.2024.01.001_bib0016","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ijpharm.2011.12.034","article-title":"The disintegration behaviour of capsules in fed subjects: a comparison of hypromellose (carrageenan) capsules and standard gelatin capsules","volume":"424","author":"Jones","year":"2012","journal-title":"Int J Pharm"},{"issue":"2","key":"10.1016\/j.xphs.2024.01.001_bib0017","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1021\/acs.molpharmaceut.8b00865","article-title":"Gastric and duodenal diclofenac concentrations in healthy volunteers after intake of the FDA standard meal: in vivo observations and in vitro explorations","volume":"16","author":"Rubbens","year":"2019","journal-title":"Mol Pharm"},{"key":"10.1016\/j.xphs.2024.01.001_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105351","article-title":"Disposition of two highly permeable drugs in the upper gastrointestinal lumen of healthy adults after a standard high-calorie, high-fat meal","volume":"149","author":"Pentafragka","year":"2020","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.xphs.2024.01.001_bib0019","unstructured":"WHO.Technical Report Series, No. 937, Annex 8, Proposal to waive in vivo bioequivalence requirements for WHO Model List of Essential Medicines immediate-release, solid oral dosage forms. 2006."},{"issue":"1-2","key":"10.1016\/j.xphs.2024.01.001_bib0020","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.ijpharm.2016.10.018","article-title":"In vitro evaluation of the impact of gastrointestinal transfer on luminal performance of commercially available products of posaconazole and itraconazole using BioGIT","volume":"515","author":"Kourentas","year":"2016","journal-title":"Int J Pharm"},{"issue":"6","key":"10.1016\/j.xphs.2024.01.001_bib0021","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/0016-5085(81)90263-8","article-title":"Gastrointestinal transit: the effect of the menstrual cycle","volume":"80","author":"Wald","year":"1981","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.xphs.2024.01.001_bib0022","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1080\/003655299750025697","article-title":"Are there changes in gastric emptying during the menstrual cycle?","volume":"34","author":"Caballero-Plasencia","year":"1999","journal-title":"Scand J Gastroenterol"},{"issue":"3","key":"10.1016\/j.xphs.2024.01.001_bib0023","doi-asserted-by":"crossref","first-page":"G602","DOI":"10.1152\/ajpgi.00051.2009","article-title":"Effects of the phases of the menstrual cycle on gastric emptying, glycemia, plasma GLP-1 and insulin, and energy intake in healthy lean women","volume":"297","author":"Brennan","year":"2009","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"10","key":"10.1016\/j.xphs.2024.01.001_bib0024","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1080\/00365520600610451","article-title":"Effects of posture on the physiology of gastric emptying: a magnetic resonance imaging study","volume":"41","author":"Steingoetter","year":"2006","journal-title":"Scand J Gastroenterol"},{"issue":"2","key":"10.1016\/j.xphs.2024.01.001_bib0025","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF01324736","article-title":"Different gastric, pancreatic, and biliary responses to solid-liquid or homogenized meals","volume":"24","author":"Malagelada","year":"1979","journal-title":"Dig Dis Sci"},{"issue":"10","key":"10.1016\/j.xphs.2024.01.001_bib0026","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/j.1365-2036.2005.02683.x","article-title":"Intestinal fluid volumes and transit of dosage forms as assessed by magnetic resonance imaging","volume":"22","author":"Schiller","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.xphs.2024.01.001_bib0027","series-title":"Drug Disposition and Characteristics of Contents in the Upper Gastrointestinal Lumen of Healthy Adults After a Standard High-Calorie High Fat Meal \u2013 Implications for the In Vitro Drug Testing Conditions","year":"2021"},{"key":"10.1016\/j.xphs.2024.01.001_bib0028","series-title":"Applied Biopharmaceutics & Pharmacokinetics","author":"Shargel","year":"1999"},{"key":"10.1016\/j.xphs.2024.01.001_bib0029","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ejpb.2015.03.009","article-title":"In-vitro simulation of luminal conditions for evaluation of performance of oral drug products: choosing the appropriate test media","volume":"93","author":"Markopoulos","year":"2015","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.xphs.2024.01.001_bib0030","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ejps.2015.11.012","article-title":"An in vitro biorelevant gastrointestinal transfer (BioGIT) system for forecasting concentrations in the fasted upper small intestine: design, implementation, and evaluation","volume":"82","author":"Kourentas","year":"2016","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.xphs.2024.01.001_bib0031","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ejpb.2018.03.002","article-title":"Interindividual and intraindividual variability of fasted state gastric fluid volume and gastric emptying of water","volume":"127","author":"Grimm","year":"2018","journal-title":"Eur J Pharm Biopharm"},{"issue":"7","key":"10.1016\/j.xphs.2024.01.001_bib0032","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3390\/pharmaceutics12070670","article-title":"Exploring the effect of esomeprazole on gastric and duodenal fluid volumes and absorption of ritonavir","volume":"12","author":"de Waal","year":"2020","journal-title":"Pharmaceutics"},{"issue":"4","key":"10.1016\/j.xphs.2024.01.001_bib0033","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1208\/s12248-023-00822-5","article-title":"Streamlining food effect assessment - are repeated food effect studies needed? An IQ analysis","volume":"25","author":"Kesisoglou","year":"2023","journal-title":"AAPS J"}],"updated-by":[{"DOI":"10.1016\/j.xphs.2025.103939","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000}},{"DOI":"10.1016\/j.xphs.2025.103939","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000}}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354924000054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354924000054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T03:37:54Z","timestamp":1768966674000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354924000054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S0022354924000054"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2024.01.001","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Understanding the Conditions Under Which Drugs are Transferred from the Stomach Through the Upper Small Intestine After a High-Calorie, High-Fat Meal","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2024.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of American Pharmacists Association.","name":"copyright","label":"Copyright"}]}}